INTERNATIONAL PATENT: CARISMA THERAPEUTICS INC. FILES APPLICATION FOR "MODIFIED IMMUNE CELLS FOR FIBROSIS AND INFLAMMATION"

GENEVA, Sept. 18 -- CARISMA THERAPEUTICS INC. (3675 Market StreetSte 200Philadelphia, Pennsylvania 19104) filed a patent application (PCT/US2025/019042) for "MODIFIED IMMUNE CELLS FOR FIBROSIS AND INFLAMMATION" on Mar 07, 2025. With publication no. WO/2025/189163, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SLOAS, David, Christopher (c/o Carisma Therapeutics Inc.3675 Market StreetSte 200Philadelphia, Pennsylvania 19104), OHTANI, Yumi (c/o Carisma Therapeutics Inc.3675 Market StreetSte 200Philadelphia, Pennsylvania 191...